Cervical-Stim​​​ is the only osteogenesis stimulator approved by the U.S. Food and Drug Administration (FDA)​ as a noninvasive, adjunctive treatment option for cervical fusion. The device uses pulsed electromagnetic f​ield (PEMF) technology to increase fusion success in patients at high risk for non-​fusion. With an overall clinical success rate of ​84 percent, Cervical-Stim increases fusion success significantly​ by 22 percent​ when used adjunctively to surgery